Akron Biotechnology Expands Its Boca Raton, Florida, Operations Facility

Posted by on Oct 24, 2014 in Newsroom | 0 comments

BOCA RATON, FL. – Akron Biotechnology, which provides novel technologies for cell therapy and regenerative medicine discovery, development and commercialization, will move into a new, larger facility that will significantly increasing space for its R&D and manufacturing operations in Boca Raton, Florida. “The expansion will play an increasingly important role in the company’s growth and allow Akron to more strongly meet the growing demand for validated products and processes for the regenerative medicine industry,” said Claudia Zylberberg, PhD, Founder/CEO of Akron Biotech....

Read More

NC Biotech Center awards $885,000 in grants, loans across state

Posted by on Oct 22, 2014 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. — The North Carolina Biotechnology Center awarded $885,586 in loans and grants the during the first quarter of its 2014-2015 fiscal year. During the same period, the Center determined that more than $13 million in outside funding was raised by companies previously awarded NCBiotech loans. NCBiotech approved 16 loans and grants to institutions and organizations across the state during the quarter running from July through September, 2014. The awards programs support life science entrepreneurship, technology commercialization and growth, and lay the groundwork for...

Read More

Argos breaks ground on Durham manufacturing facility

Posted by on Oct 22, 2014 in Newsroom | 0 comments

DURHAM — Argos Therapeutics took a $56.6 million symbolic leap of faith Tuesday, breaking ground on a 97,500-square foot facility that it hopes will one day manufacture a cutting-edge cancer therapy that is still awaiting approval from federal regulators. “We’re celebrating today, but we’re not quite there yet,” Argos CEO Jeff Abbey said before he and several business partners and local officials put ceremonial shovels into the ground. Argos, currently located on Technology Drive in northern Durham, is in the final, “Phase 3,” stage of clinical tests for its first product: a...

Read More

BioFlorida Conference Promotes Collaboration, Growth and Innovation in Florida’s Life Sciences Industry

Posted by on Oct 21, 2014 in Newsroom | 0 comments

FORT LAUDERDALE, FL. – More than 400 business executives, scientists and other stakeholders gathered in Ft. Lauderdale last week for the 17th Annual BioFlorida Conference, the hallmark industry event for Florida’s life sciences industry. The Conference concluded on Tuesday, October 14th after two days of hearing experts from leading universities, research institutions and companies throughout the state discuss advancements in key areas of innovation and growth in Florida such as medical technology, cancer research, Alzheimer’s research, marine biotechnology, medical tourism...

Read More

Viamet Pharma raises $60M

Posted by on Oct 21, 2014 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. –Viamet Pharmaceuticals Holdings, LLC (Viamet) today announced the closing of a $60 million Series D financing provided by Brandon Point Industries Limited (Brandon Point) working with Woodford Investment Management. In making this commitment, Brandon Point and Woodford Investment Management join Viamet’s current investor syndicate, which includes Novartis Venture Fund, Lilly Ventures, Hatteras Venture Partners, Intersouth Partners, Lurie Holdings and Astellas Venture Management. Proceeds from the financing will be used to advance the company’s pipeline of...

Read More

Patheon to Add 488 Jobs in Greenville

Posted by on Oct 21, 2014 in Newsroom | 0 comments

DURHAM, N.C. — Patheon is adding 488 jobs to its Greenville facility, Governor Pat McCrory announced at the company earlier this month. The jobs will be created by the end of 2019 as part of a planned $159 million expansion of the site. Gov. McCrory announces 488 jobs at PatheonThe expansion will increase and modernize manufacturing capacity, making Greenville the home of Patheon’s sterile fill facility. The expansion will also solidify the company’s pharmaceutical development services offerings. Patheon is a business unit of DPx Holdings. “To know that a growing...

Read More